Senores Pharmaceuticals Reports Strong Q1 FY27 Growth with Higher Profit MM Desk 28 July, 2026 Senores Pharmaceuticals Limited, a global research-driven pharmaceutical company focused on specialty, niche and complex medicines Read More
Senores Pharmaceuticals Announces Strategic US Joint Venture to Expand Federal Market Access MM Desk 7 April, 2026 Senores Pharmaceuticals, Inc (SPI), a wholly owned subsidiary of Senores Pharmaceuticals Limited, has announced the Read More
Senores Pharmaceuticals Secures Philippine FDA Approval for 10 New Products, MM Desk 6 December, 2025 Senores Pharmaceuticals Limited has received marketing authorizations from the Philippine Food and Drug Administration (FDA) Read More